Legal & General Group
THRD

Legal & General Group’s Third Harmonic Bio THRD Stock Holding History

Legal & General Group’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,323
Closed -$12.6K – 3458
2025
Q2 		$12.6K Buy
2,323
+369
+19% +$1.84K ﹤0.01% 3199
2025
Q1 		$6.78K Hold
1,954
– – ﹤0.01% 3241
2024
Q4 		$20.2K Hold
1,954
– – ﹤0.01% 3017
2024
Q3 		$26.5K Buy
1,954
+347
+22% +$4.3K ﹤0.01% 2940
2024
Q2 		$20.8K Hold
1,607
– – ﹤0.01% 3001
2024
Q1 		$15.2K Hold
1,607
– – ﹤0.01% 3082
2023
Q4 		$17.6K Sell
1,607
-209
-12% -$1.66K ﹤0.01% 3077
2023
Q3 		$11.6K Hold
1,816
– – ﹤0.01% 3238
2023
Q2 		$8.73K Buy
1,816
+617
+51% +$2.94K ﹤0.01% 3333
2023
Q1 		$4.94K Hold
1,199
– – ﹤0.01% 3305
2022
Q4 		$5.14K Buy
+1,199
New +$20.1K ﹤0.01% 3346

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Legal & General Group's THRD Position: Q3 2025 in Review

Legal & General Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 2,323 shares — an estimated $12.6K sold.

Legal & General Group first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $26.5K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Legal & General Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Legal & General Group sold 2,323 Third Harmonic Bio shares in Q3 2025, an estimated $12.6K.
  • Legal & General Group first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Legal & General Group's Third Harmonic Bio position peaked at $26.5K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Legal & General Group's 13F filing for Q3 2025, filed 13 Nov 2025.